Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
The purpose of this study is in non small-cell lung cancer stage IV et IIIB (T4 with pleural effusion) in elderly dependent patients with evaluation of the sequence Gemcitabine first line followed by Erlotinib when progression versus Erlotinib first line followed by Gemcitabine when progression
Non Small Cell Lung Cancer
DRUG: TARCEVA|DRUG: Gemzar
A multicenter phase II trial,prospective,randomized,open,non comparative